|
Volumn 56, Issue 3, 2002, Pages 139-143
|
Urinary proteins and renal dysfunction in patients with multiple myeloma
|
Author keywords
Multiple myeloma; Renal function; Urinary proteins
|
Indexed keywords
ALPHA 1 MICROGLOBULIN;
ANTINEOPLASTIC AGENT;
BETA 2 MICROGLOBULIN;
BETA2 GLYCOPROTEIN;
CREATININE;
GLYCOPROTEIN;
LYSOZYME;
N ACETYL BETA GLUCOSAMINIDASE;
OROSOMUCOID;
PEPSIN A;
RETINOL BINDING PROTEIN;
TRYPSIN;
UNCLASSIFIED DRUG;
UREA;
ANEMIA;
BONE PAIN;
CANCER MORTALITY;
CANCER PAIN;
CANCER STAGING;
CANCER SURVIVAL;
CREATININE BLOOD LEVEL;
CREATININE CLEARANCE;
DIAGNOSTIC ACCURACY;
DISEASE ASSOCIATION;
DISEASE COURSE;
DISEASE SEVERITY;
DOSE RESPONSE;
FOLLOW UP;
GLOMERULUS FILTRATION RATE;
HUMAN;
KIDNEY BIOPSY;
KIDNEY FAILURE;
KIDNEY FUNCTION;
KIDNEY INJURY;
LABORATORY TEST;
MULTIPLE MYELOMA;
PATHOGENESIS;
PATHOLOGIC FRACTURE;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN URINE LEVEL;
RECURRENT INFECTION;
RELIABILITY;
REVIEW;
TREATMENT OUTCOME;
UREA BLOOD LEVEL;
URINE FLOW RATE;
|
EID: 0036228594
PISSN: 07533322
EISSN: None
Source Type: Journal
DOI: 10.1016/S0753-3322(02)00171-3 Document Type: Article |
Times cited : (15)
|
References (33)
|